AiCube, lo spazzolino che misura la glicemia
AiCube e Pq Design Group stanno collaborando per realizzare uno spazzolino che permette la misurazione della glicemia attraverso la saliva. E studiano anche come rilevare il Covid. La startup innovativa AiCube ha brevettato un sistema che monitora lo stato di salute delle persone in maniera non invasiva. Da tempo la società con sede a Milano si è focalizzata nella prevenzione proattiva e nella medicina predittiva attraverso handyman dublin l’elaborazione di particolari algoritmi e attraverso il machine learning. Attualmente i sistemi di rivelazione del diabete sono fortemente invasivi e possono creano problemi a molti pazienti. Fino ad oggi la glicemia si misura mediante un normale prelievo di sangue venoso dal braccio oppure con automonitoraggio. Questo strumento rileva la glicemia mediante una goccia di sangue capillare, prelevata dai polpastrelli delle dita delle mani.
Il nostro scopo è di supportare le startup come AiCube nello sviluppo di prodotti complessi, affiancando l’azienda in tutte le fasi di progettazione e sviluppo di un prodotto innovativo. Per realizzare il dispositivo il nostro studio sta collaborando con la startup, fornendo supporto nel design del prodotto e collaborando con il team di ingegneri ed esperti di elettronica e microfluidica coinvolti nel progetto. Abbiamo lavorato seguendo le indicazioni di AiCube, che sono state subito molto chiare: rendere meno invasivo possibile il sistema di monitoraggio del diabete. SEO Expert
Convey a feeling of normality
It was important for us at Pq design group to imagine a new device, capable of transmitting a feeling of normality to users. We wanted the final product design to have the feeling of a “normal” personal care and hygiene product and not a medical product. We have worked to de-medicalise the product by focusing entirely on the concept of non-invasiveness. The expected result is that the user will have the sensation of making a normal daily gesture and not a withdrawal. This is the fulcrum of all planning.
Prevention with the AiCube toothbrush
The project is called DOC.D and was created to make diabetes control easier and less invasive. The technology studied by AiCube allows the possibility of making early diagnoses of diseases. These, if diagnosed in time, can be treated or at least reduce the complications. Secondary prevention is made possible by collecting the values of specific biomarkers on a daily or weekly basis, in order to have statistically significant data. Handyman Dublin
The patented device collects a saliva sample using the innovative electric toothbrush. The saliva sample is then piped into the base. Here the value of the reference biomarker is measured, such as glucose for diabetes. And in the future it will also be able to carry out Covid-like tests (once clinically tested).
How the toothbrush works
The device called DOC.D (Data Organized Collector Devices) includes a physiological liquid sample acquisition device (saliva), a POP (Point of Prevention) analyzer with disposable cartridge. And a server called “The Cube”, connected wirelessly, which processes the data using a Machine Learning algorithm.
The system also provides user identification through the use of a fingerprint reader. Which is used to prevent the association of the analyzed sample with an incorrect user. The device consists of several sensors and indicators (visual and audible) to inform the user of correct sample collection. Your teeth are brushed, the sample is collected, and then the toothbrush will go back into the (POP) for analysis and recharging.
Type 2 diabetes mellitus
The AiCube toothbrush was created to control type 2 diabetes mellitus in particular. This is the most frequent form of diabetes, affecting 90% of diabetes cases. And it is typical of mature age. Those affected have an insufficient amount of insulin to meet the body’s needs (insulin secretion deficiency). Or the insulin produced does not act satisfactorily (insulin resistance). It is therefore essential for the patient to have real-time information on changes in glucose levels. It is possible to do this discreetly, thanks to the daily use of this device. This is the objective that Pq design group and AiCube are pursuing.